Fig. 7
From: Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
Graphical representation of drug-loaded theranostic MSN platform designed to have pH-sensitivity as a trigger for drug release to elicit a chemotherapeutic effect